Methods for detecting the onset, progression and regression of g

Details Methods for detecting the onset, progression and regression of g Methods for detecting the onset, progression and regression of g

1991-01-24

1994-10-18

Alexander, Lyle A.

Chemistry: analytical and immunological testing

Cancer

436813, 436510, G01N 3300

Patent

active

053568176

ABSTRACT:
A method for detecting the progression or regression of a gynecologic cancer in a female by:

REFERENCES:
patent: 4116776 (1978-09-01), Dalbow et al.
patent: 4123224 (1978-10-01), Givner et al.
patent: 4144031 (1979-03-01), Acevedo et al.
patent: 4310455 (1982-01-01), Bahl
patent: 4387166 (1983-06-01), Maes
patent: 4489166 (1984-12-01), Joshi
patent: 4514505 (1985-04-01), Canfield et al.
patent: 4804626 (1989-02-01), Bellet et al.
Cole et al. "Urinary Gonadotropin Fragment (UGF) Measurements in the Diagnosis and Management of Ovarian Cancer", The Yale Journal of Biology and Medicine 62 (1989), 367-378.
Sheth, N. A. et al, "Inappropriate Secretion of Human Placental Lactogen and .beta.-Subunit of hCG by Cancer of the Uterine Cervix", Gynecol Oncol 11 (3), 1981, Cancer Research Inst., Parel, Bombay, India.
Papapetrou, P. D. and Nicopoulou, S. C., The Origin of a Human Chorionic Gonadotropin Beta-Subunit Core Fragment in the Urine of Patients with Cancer, A. Endocrinologica, 112, 415-422 (1986).
Cole, L. A., Wang, Y., Elliott, M., Latif, M., Chambers, J. T., Chambers, S. K. and Schwartz, P. E., Urinary Human Chorionic Gonadotropin Free Beta-Subunit and Beta-Core Fragment: A New Marker of Gynecologic Cancers, Cancer Res., 48, 1356-1360 (1988).
1987 Asco Abstract.
Wehmann, R. E. and Nisula, B. C., Metobolic Clearance Rates of the Subunits of Human Chorionic Gonadotropin in Man, J. Clin. Endocrinol. Metab., 48, 753-759 (1979).
R. O. Hussa, Human Chorionic Gonadotropin, A Clinical Marker: Review of its Biosynthesis, Ligand Rev., 3, 1-43 (1981).
Wang, Y., Schwartz, P. E. and Cole, L. A., Serum hCG Investigation in Patients with Non-Trophoblastic Cancer, J. Obstet. Gynecol. China, (no date provided).
Birken, S., Armstrong, E. G., Kolks, M. A. G., Cole, L. A., Agosto, G. M., Krichevsky, A. and Canfiled, R. E., The Structure of the Human Chorionic Gonadotropin Beta Core Fragment from Pregnancy Urine, Endocrinology, vol. 123, No. 1, 572-583 (No date provided).
Schroeder, H. R. and Halter, C. M., Specificity of Human Beta-Choriogonadotropin Assays for the Hormone and for an Immunoreactive Fragment Present in Urine During Normal Pregnancy, Clin. Chem., 29, 667-671 (1983).
Lefort, G. P., Stolk, J. M. and Nisula, B. C., Renal Metobolism of the Beta-Subunit of Human Choriogonadotropin in the Rat, Endocrinology, 119, 924-931 (1986).
Cole, L. A., Kroll, T. G., Ruddon, R. W. and Hussa, R. O., Differential Occurrence of Free B and Free A Subunits of Human Chorionic Gonadotropin in Pregnancy Sera, J. Clin. Endocrinol. Metab., 58, 1200-1202 (1984).
Cole, L. A., Occurrence and Properties of Glycoprotein Hormone Free Subunits, in Microheterogeneity of Glycoprotein Hormones (H. Grotjan and B. Keel, Eds.), CRC Press, New York, (No date provided).
Cole, L. A., Hartle, R. J., Laferla, J. J. and Ruddon, R. W., Detection of the Free Beta-Subunit of Human Chorionic Gonadotropin in Cultures of Normal and Malignant Trophoblast Cells, Pregnancy Sera, and Sera of Patients with Choriocarcinoma, Endocrinology, 113, 1176-1178 (1983).
Atack, D. B., Nisker, J. A., Allen, H. H., Tustanoff, E. R. and Levin, L., CA 125 Surveillance and Second-Look Laparotomy in Ovarian Carcinoma, Am. J. Obstet. Gynecol., 154, 287-289 (1986).
Schwartz, P. E., Chambers, S. K., Chambers, J. T., Gutmann, J., Katopodis, N. and Foemmel, R. S., Circulating Tumor Markers in the Monitoring of Gynecologic Malignancies, Cancer, 60, 353-361 (1987).
Alvarez, R. D., To, A., Boots, L. R., Shingleton, H. M., Hatch, K. D., Hubbard, J., Soong, S. J. and Potter, M. E., CA 125 as a Serum Marker for Poor Prognosis in Ovarian Malignancies, Gynecol. Oncol., 26, 284-289 (1987).
E. Silverberg, Cancer Statistics, CA-A Cancer J. Clinicians, 6, 9-26 (1986).
Schwartz, P. E., Gynecologic Cancer, In J. A. Spittle, Jr. (ed.), Clinical Medicine, pp. 1-44. Philadelphia: Harper and Row, (1986).
Bast, R. C., Kung, T. L., St. John, E., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R., Leavitt, T., Griffiths, T., Parker, L., Zurawaski, V. R. and Knapp, R. C., A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer, N. Engl. J. Med., 309, 883-887 (1983).
Masure, H. R., et al, "Charac. of a Small Molec. Siz Urin. Immunoreactive Human Chorionic Gonado. (hcG)-Like Substance Produced by Normal Placenta and by hCG-Secreting Neoplasms", J. of Clin. Endocrin. & Metab., 53, No. 5, pp. 1014-1020 (no date provided).
Seski, J., et al, "Chemotherapy for Endometrial Cancer", Annual Clinical Conf. on Cancer, vol. 29, pp. 327-334 (no date provided).
Yajima, A., et al, "Effect of Cytologic Screening on the Detection of Cer. Carcinoma", Obst. & Gyn., vol. 59, No. 5, Sep. 28, 1981.
Jordan, S., et al, "The Significance of Cerv. Cytologic Dysplasia", Acta. Cytologica, 0001-5547/81/2503-0237/pp. 2347-244 (no date provided).
Schwartz, P. E., et al, "Eval. of Squamous Cell Carcin. Antigen (SCC) and Lipid-Assoc. Sialic Acid (LSA) in Monitoring Patients w/Cerv. Cancer", Proceedings of ASCO, 6, Gynecological Tumors, Mar. 1987, #445.

Affiliated with

Also associated with

Rating

Methods for detecting the onset, progression and regression of g does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for detecting the onset, progression and regression of g, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting the onset, progression and regression of g will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2371861